CARISOPRODOL PRODUCTS BECOME SCHEDULE IV CONTROLLED SUBSTANCES
Effective January 11, 2012 all carisoprodol products will become Schedule IV controlled substances under federal law. Pharmacists should note that federal Controlled Substances Act regulations require any DEA registrant (i.e., a pharmacy) that possesses any carisoprodol stock must take an inventory of all stocks of carisoprodol on hand on or before January 11, 2012.  That inventory must be maintained with all other controlled substance inventory records.

Joint Newsletter - NHSHP and NHPA
Oct 2011

July 2011

Feb 2011

    Legislative Calendar (Current)

                  Final Legislative Report 2011
 

       List of Bills Being Tracked for NHSHP

Monthly Prescribing Reference Clinical Charts

Understanding ACPE Pharmacist's Continuing Education

Approved Risk Evaluation & Mitigation Strategies (REMS)

   ASHP ADVANTAGE
  Offers a full range of educational offerings, including webinars,
  web-based CE, live educational symposia, regional workshops,
  & publications for health care professionals.